Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
Authors
Keywords
-
Journal
BMC CANCER
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-04
DOI
10.1186/s12885-019-6278-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism
- (2018) Wangie Yu et al. Scientific Reports
- Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
- (2018) Claudia Omarini et al. Cancer Management and Research
- The Comparative Toxicogenomics Database: update 2019
- (2018) Allan Peter Davis et al. NUCLEIC ACIDS RESEARCH
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis
- (2017) Zhongling Zhu et al. JOURNAL OF NEUROCHEMISTRY
- NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation
- (2017) Xiao-Ming Meng et al. LABORATORY INVESTIGATION
- The EMT spectrum and therapeutic opportunities
- (2017) Dominic C. Voon et al. Molecular Oncology
- Triple-negative breast cancer and the potential for targeted therapy
- (2017) Jing-Ru Jhan et al. PHARMACOGENOMICS
- Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trials
- (2016) Fausto Petrelli et al. BREAST CANCER RESEARCH AND TREATMENT
- Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer
- (2016) Evan C. Lien et al. NATURE CELL BIOLOGY
- Genenames.org: the HGNC and VGNC resources in 2017
- (2016) Bethan Yates et al. NUCLEIC ACIDS RESEARCH
- The Comparative Toxicogenomics Database: update 2017
- (2016) Allan Peter Davis et al. NUCLEIC ACIDS RESEARCH
- KEGG: new perspectives on genomes, pathways, diseases and drugs
- (2016) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- The tandem duplicator phenotype as a distinct genomic configuration in cancer
- (2016) Francesca Menghi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia
- (2016) Jhih-Pu Syu et al. Oncotarget
- Downregulation of vimentin expression increased drug resistance in ovarian cancer cells
- (2016) Yi Huo et al. Oncotarget
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- The Human Phenotype Ontology: Semantic Unification of Common and Rare Disease
- (2015) Tudor Groza et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Evaluation of antimicrobial effects of commercial mouthwashes utilized in South Korea
- (2015) Su-Jeong Yang et al. BMB Reports
- Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links
- (2015) Akshada Sawant et al. DNA REPAIR
- The Disease Ontology: fostering interoperability between biological and clinical human disease-related data
- (2015) Lynn M. Schriml et al. MAMMALIAN GENOME
- Visual annotation display (VLAD): a tool for finding functional themes in lists of genes
- (2015) Joel E. Richardson et al. MAMMALIAN GENOME
- GeneWeaver: data driven alignment of cross-species genomics in biology and disease
- (2015) Erich Baker et al. NUCLEIC ACIDS RESEARCH
- ChEBI in 2016: Improved services and an expanding collection of metabolites
- (2015) Janna Hastings et al. NUCLEIC ACIDS RESEARCH
- sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo
- (2015) Guoliang Ma et al. World Journal of Surgical Oncology
- Micheliolide overcomes KLF4-mediated cisplatin resistance in breast cancer cells by downregulating glutathione
- (2015) Yongsheng Jia et al. OncoTargets and Therapy
- Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation
- (2015) Ulrike Keitel et al. Oncotarget
- Secreted Clusterin Gene Silencing Enhances Chemosensitivity of A549 Cells to Cisplatin Through AKT and ERK1/2 Pathwaysin Vitro
- (2014) Biyuan Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
- (2014) M. D. Burstein et al. CLINICAL CANCER RESEARCH
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Activation of VCAM-1 and Its Associated Molecule CD44 Leads to Increased Malignant Potential of Breast Cancer Cells
- (2014) Pei-Chen Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The GOA database: Gene Ontology annotation updates for 2015
- (2014) Rachael P. Huntley et al. NUCLEIC ACIDS RESEARCH
- Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data
- (2014) Warren A. Kibbe et al. NUCLEIC ACIDS RESEARCH
- Augmentation of NAD+ by NQO1 attenuates cisplatin-mediated hearing impairment
- (2014) H-J Kim et al. Cell Death & Disease
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
- (2013) A. Prat et al. ONCOLOGIST
- Protective role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in cisplatin-induced nephrotoxicity
- (2013) Gil-Tae Gang et al. TOXICOLOGY LETTERS
- EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
- (2012) Alexandria M Haslehurst et al. BMC CANCER
- Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
- (2012) Xin Fu et al. FEBS LETTERS
- Acquired differential regulation of caspase-8 in cisplatin-resistant non-small-cell lung cancer
- (2012) I Paul et al. Cell Death & Disease
- Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells
- (2011) David J Taylor et al. BMC CANCER
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- GeneWeaver: a web-based system for integrative functional genomics
- (2011) Erich J. Baker et al. NUCLEIC ACIDS RESEARCH
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- NADPH oxidase 4 is an oncoprotein localized to mitochondria
- (2010) Kelly A. Graham et al. CANCER BIOLOGY & THERAPY
- Up-regulation of fas reverses cisplatin resistance of human small cell lung cancer cells
- (2010) Wei Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Context-Dependent Bidirectional Regulation of the MutS Homolog 2 by Transforming Growth Factor Contributes to Chemoresistance in Breast Cancer Cells
- (2010) Y. Yu et al. MOLECULAR CANCER RESEARCH
- Mismatch Repair Protein Deficiency Compromises Cisplatin-induced Apoptotic Signaling
- (2009) Ryan P. Topping et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of copper transporters in resistance to platinating agents
- (2008) Cara A. Rabik et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now